IntelGenx: 8% Dividend and a Potential Drug Delivery Revolution 💊

[View in browser]( *|MC_PREVIEW_TEXT|* [Intel-Gen-X-LOGO]( [Investment Opportunity: Be Part of IntelGenx's $510B Market Disruption]( What if you could invest in a healthcare startup offering an 8% dividend? But we’re not talking about a moonshot biotech that hopes to develop a compound that MIGHT work. [IntelGenx aims to disrupt the $510B pharmaceutical industry](…from the inside. Remarkable as it sounds, 40% of adults struggle with swallowing pills. IntelGenx’s oral film delivery system built off similar technology as Listerine strips, a product the chairman and founder co-invented. [Intel-Gen-X-Image-1]( This reimagined drug delivery method is faster, more efficient, and patient-friendly than current medication intake methods. IntelGenx is partnering with leading pharmaceutical companies to deliver their medications, potentially making IntelGenx the UPS to their Amazon. And now you can be a part of this opportunity. [IntelGenx preferred stock offering is available now on the My IPO platform](with a minimum investment of just $750. - 💸Hybrid Return Structure with 8% Dividend: 8% dividend plus the option to convert to common or 50% return on principal after 5 years if unconverted - 💰 Massive Potential Market: $510B market in the pharmaceutical industry - 💪Strong Pipeline: Over 80 issued and pending patents on the pipeline - 📉Advantageous Business Model: Provides pharma and biotech world with enabling technology vs. onerous spend on marketing and drug discovery. - 🌐Proven Technology & Pharma Veterans: Experienced leadership at top firms like Glaxo plus thin-film technology, reminiscent of dissolvable breath strips, to innovate in pharmaceutical delivery. Join the drug delivery revolution with IntelGenx. [Click here to invest in IntelGenx's Series A Convertible Cumulative Preferred Stock.]( AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT IS AVAILABLE [HERE](. ADDITIONAL INFORMATION CONCERNING[RISK FACTORS]( RELATED TO THE OFFERING CAN BE FOUND IN THE OFFERING CIRCULAR.THIS PAGE MAY INCLUDE ''FORWARD-LOOKING STATEMENTS.'' TO THE EXTENT THAT THE INFORMATION PRESENTED IN THIS PRESENTATION DISCUSSES FINANCIAL PROJECTIONS, INFORMATION, OR EXPECTATIONS ABOUT INTELGENX TECHNOLOGIES CORP (“INTELGENX”) BUSINESS PLANS, RESULTS OF OPERATIONS, PRODUCTS OR MARKETS, OR OTHERWISE MAKES STATEMENTS ABOUT FUTURE EVENTS, SUCH STATEMENTS ARE FORWARD-LOOKING. SUCH FORWARD-LOOKING STATEMENTS CAN BE IDENTIFIED BY THE USE OF WORDS SUCH AS ''SHOULD,'' ''MAY,'' ''INTENDS,'' ''ANTICIPATES,'' ''BELIEVES,'' ''ESTIMATES,'' ''PROJECTS,'' ''FORECASTS,'' ''EXPECTS,'' ''PLANS,'' AND ''PROPOSES.''ALTHOUGH INTELGENX BELIEVES THAT THE EXPECTATIONS REFLECTED IN THESE FORWARD-LOOKING STATEMENTS ARE BASED ON REASONABLE ASSUMPTIONS, THERE ARE A NUMBER OF RISKS AND UNCERTAINTIES THAT COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM SUCH FORWARD-LOOKING STATEMENTS. YOU ARE URGED TO CAREFULLY REVIEW AND CONSIDER ANY CAUTIONARY STATEMENTS AND OTHER DISCLOSURES, INCLUDING THE STATEMENTS MADE UNDER THE HEADING "RISK FACTORS" AND ELSEWHERE IN THE OFFERING STATEMENT FILED WITH THE SEC. FORWARD-LOOKING STATEMENTS SPEAK ONLY AS OF THE DATE OF THE DOCUMENT IN WHICH THEY ARE CONTAINED, AND INTELGENX DOES NOT UNDERTAKE ANY DUTY TO UPDATE ANY FORWARD-LOOKING STATEMENTS EXCEPT AS MAY BE REQUIRED BY LAW.THE OFFERING WILL BE MADE ONLY BY MEANS OF AN OFFERING CIRCULAR. AN OFFERING STATEMENT ON FORM 1-A RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION AND HAS BECOME QUALIFIED. THE SECURITIES OFFERED BY INTELGENX ARE HIGHLY SPECULATIVE. INVESTING IN SHARES OF INTELGENX INVOLVES SIGNIFICANT RISKS. THE INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT COULD BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET CURRENTLY EXISTS FOR THE SECURITIES, AND IF A PUBLIC MARKET DEVELOPS FOLLOWING THE OFFERING, IT MAY NOT CONTINUE. INTELGENX DOES NOT INTEND TO PUBLICLY LIST ITS PREFERRED STOCK. ADDITIONAL INFORMATION ON INTELGENX , THE OFFERING AND ANY OTHER RELATED TOPICS, PLEASE REVIEW THE FORM 1-A OFFERING CIRCULAR THAT CAN BE FOUND BY SEARCHING FOR INTELGENX TECHNOLOGIES CORP. UNDER FILINGS/COMPANY FILINGS SEARCH ON WWW.SEC.GOV. ADDITIONAL INFORMATION CONCERNING RISK FACTORS RELATED TO THE OFFERING, INCLUDING THOSE RELATED TO THE BUSINESS, GOVERNMENT REGULATIONS, INTELLECTUAL PROPERTY AND THE OFFERING IN GENERAL, CAN BE FOUND IN THE RISK FACTOR SECTION OF THE FORM 1-A OFFERING CIRCULAR. [InvestingChannel Logo](#) Follow us on: [Facebook Logo]( [LinkedIn Logo]( [Twitter Logo]( [Instagram Logo]( To ensure delivery of all emails, [allow us on your list](. Manage your subscriptions with our [preference center](. [Unsubscribe here.]( View our privacy policy [here](. Copyright ©2024 InvestingChannel. All rights reserved. 1325 Avenue of the Americas, Floor 27 & 28 New York, New York 10019 PLEASE NOTE:InvestingChannel, Inc. (“InvestingChannel”, “we” or “our”), operates this newsletter. InvestingChannel and its employees are not registered investment advisers, broker-dealers, or members of any association for other research providers in any jurisdiction and are not qualified to give financial advice. Our website and newsletters are for entertainment purposes only. This newsletter is NOT a source of unbiased information. InvestingChannel does not provide investment advice, endorsement, analysis, or recommendations with respect to any securities, and its services should never be construed as any endorsement of or judgment about any security. You are reading this newsletter because you have subscribed via our opt-in signup form on InvestingChannel.com or one of our network partners’ websites. If you have subscribed by mistake, you may unsubscribe [HERE](. This is a PAID ADVERTISEMENT provided to customers/subscribers of InvestingChannel. Although we have sent you this email, InvestingChannel does NOT endorse this product nor is it responsible for the content of this advertisement. Further, we make no guarantee or warranty about the product or service in the advertisement above. IMPORTANT DISCLAIMER:In accordance with Section 17(b) of the Securities Act of 1933, you are hereby advised that an unaffiliated third party (“advertiser”) is paying InvestingChannel on a cost-per-click basis, which may exceed a fee of over $1,000.00 in cash, as compensation for the distribution of this advertisement. InvestingChannel has not determined if the statements and opinions of the advertiser are accurate, correct, or truthful. The purpose of this advertisement, like any advertisement, is to provide publicity for the advertiser and its products or services. You should not rely on the information presented; you should do independent research to form your own opinion and decision. Information in our disseminated emails does not constitute investment, legal, or tax advice upon which you should rely. The purchase of securities may result in the loss of your entire investment. You understand that this advertisement and our website do not constitute a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. This advertisement is not a solicitation, offer, inducement, invitation, or recommendation to buy securities, services, or product of the advertiser. An offer to buy or sell securities can be made only by a disclosure document that complies with applicable securities laws and only in the states or other jurisdictions in which the security is eligible for sale. Advertisements distributed through emails are not disclosure documents. If you are considering purchasing any securities of the advertiser, you should call your state securities regulator to determine if the security may be sold in your state. You should read and review, if and to the extent available, any information concerning the advertiser available at the websites of the U.S. Securities and Exchange Commission (SEC) at []( and the Financial Industry Regulatory Authority (FINRA) at [](. Many companies have information filed with state securities regulators who may be able to supply you with additional information. We also strongly recommend that you read the SEC’s internet stock fraud advisory at [(, as well as related information from FINRA on how to invest carefully. You are responsible for verifying all claims and conducting your own due diligence. We strongly encourage you to conduct your own research before making any investment decisions. You agree and acknowledge that any hyperlinks we have provided to the website of (1) an advertised company, (2) the party issuing or preparing the information for the advertiser, or (3) other information contained in our disseminated emails are only for your reference and convenience. We are not responsible for the accuracy or reliability of external websites, nor are we responsible for the content, advertising, opinions, products, or other materials on external websites or information sources. If you use, act upon, or make decisions relying on information contained in any disseminated email, external website, or hyperlink, you do so at your own risk and agree to hold us and our officers, directors, shareholders, affiliates, and agents harmless. You acknowledge that you are not relying on us, and we are not liable for any actions you take based on any information contained in any disseminated email, website, or hyperlink. You also acknowledge that we are not an investment advisory service, a broker-dealer, or an investment adviser. You acknowledge that you will consult with your own advisers regarding any decisions about any advertiser. InvestingChannel, Inc., P.O. Box 118, New York, NY 10018 [Link](